Precision Medicine is the next generation of healthcare research that has the potential to provide significant benefits to patients and affect strategic shifts in the way healthcare is delivered. It uses an individual's genetic profile to guide decisions about the prevention, diagnosis, and treatment of disease. Developing new diagnostic tests and expanding the use of biomarkers enables the identification of the molecular cause of disease, and ultimately supports the development of novel, more precisely targeted treatments.
Plans in development. Precision Medicine Clinics combine genomics, bioinformatics analysis and clinical interpretation to support patients with unsolved medical needs.
Clinical trials are the means by which investigational agents, devices, or biologics, such as chemotherapy agents, blood products, or gene therapies are scientifically evaluated for safety and efficacy.
The UCL Institute for Precision Medicine aims to accelerate the development of novel drugs and targeted therapies (antisense oligonucleotide, cell and gene therapies).
Close
